These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis. Kumpel BM; Leader KA; Merry AH; Hadley AG; Poole GD; Blancher A; Goossens D; Hughes-Jones NC; Bradley BA Eur J Immunol; 1989 Dec; 19(12):2283-8. PubMed ID: 2481589 [TBL] [Abstract][Full Text] [Related]
23. Direct ADCC lysis of O,Rh-positive (R1R2) erythrocytes by lymphocytes of individuals sensitized against antigen D. Bakács T; Ringwald G; Jókuti I Immunol Lett; 1982 Jan; 4(1):53-7. PubMed ID: 6800939 [TBL] [Abstract][Full Text] [Related]
24. Antibody dependent cell mediated cytotoxicity on human cervical carcinoma cell line, ME-180, with human monoclonal antibody. Osumi K; Nagao J; Yuasa H; Fujimoto H; Hagiwara H; Kodera Y; Ohno R Cancer Lett; 1992 Feb; 62(2):179-83. PubMed ID: 1540945 [TBL] [Abstract][Full Text] [Related]
25. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579 [TBL] [Abstract][Full Text] [Related]
26. Phagocytosis by human monocytes of red cells sensitized with monoclonal IgG1 and IgG3 anti-D. Hadley AG; Kumpel BM Vox Sang; 1989; 57(2):150-1. PubMed ID: 2506695 [No Abstract] [Full Text] [Related]
27. Human and murine anti-Rh monoclonal antibodies. A comparison of serological, immunochemical, cellular and functional activity. Kumpel BM; Leader KA; Poole GD; Yendle JE; Judson PA Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):187-201. PubMed ID: 3145548 [No Abstract] [Full Text] [Related]
28. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions. Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858 [TBL] [Abstract][Full Text] [Related]
29. Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving. Beum PV; Lindorfer MA; Taylor RP J Immunol; 2008 Aug; 181(4):2916-24. PubMed ID: 18684983 [TBL] [Abstract][Full Text] [Related]
30. Human lymphocyte antibody-dependent cell-mediated cytotoxicity (ADCC) toward human red blood cells. Shaw GM; Levy PC; LoBuglio AF Blood; 1978 Oct; 52(4):696-705. PubMed ID: 99198 [No Abstract] [Full Text] [Related]
31. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198 [TBL] [Abstract][Full Text] [Related]
32. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies. Hadley AG; Kumpel BM; Merry AH Clin Lab Haematol; 1988; 10(4):377-84. PubMed ID: 3150696 [TBL] [Abstract][Full Text] [Related]
33. [Inhibitory effect of human plasma on 17-1A-dependent cellular cytotoxicity]. Kimoto Y; Taguchi T Gan To Kagaku Ryoho; 1987 Feb; 14(2):459-66. PubMed ID: 3813574 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of a panel of human monoclonal antibodies to D and exploration of the synergistic effects of blending IgG1 and IgG3 antibodies on their in vitro biologic function. Armstrong-Fisher SS; Carter MC; Downing I; Fraser RH; Inglis GE; Allan EK; Mackie A; Prowse CV; Templeton JG; Thorpe SJ; Urbaniak SJ Transfusion; 1999 Sep; 39(9):1005-12. PubMed ID: 10533828 [TBL] [Abstract][Full Text] [Related]
35. Lack of evidence for IgM-induced ADCC: studies with monoclonal and polyclonal antibodies. Rumpold H; Wiedermann G; Scheiner O; Kraft D; Stemberger H Immunology; 1981 May; 43(1):161-70. PubMed ID: 6788680 [TBL] [Abstract][Full Text] [Related]
36. Antibody dependent cell mediated cytotoxicity against anti-D sensitized human erythrocytes. Influence of various effector cells and enzyme treatment of the target cells. Samdal HH; Michaelsen TE; Heier HE; Nordhagen R APMIS; 1988 Mar; 96(3):250-6. PubMed ID: 3126786 [TBL] [Abstract][Full Text] [Related]
37. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A. Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf IG Z Gastroenterol; 2000 Aug; 38(8):615-22. PubMed ID: 11031784 [TBL] [Abstract][Full Text] [Related]
38. Rhesus immunization in male volunteers: changes in lymphocyte functions following secondary immunizations in anti-D responders and non-responders. Barclay GR; Greiss MA; McCann MC; Urbaniak SJ Br J Haematol; 1983 Apr; 53(4):629-40. PubMed ID: 6299324 [TBL] [Abstract][Full Text] [Related]
39. Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies. Lubeck MD; Kimoto Y; Steplewski Z; Koprowski H Cell Immunol; 1988 Jan; 111(1):107-17. PubMed ID: 3338092 [TBL] [Abstract][Full Text] [Related]
40. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells. Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]